(Q73407572)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

J A Panepinto

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Magid

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

M J Rewers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P A Lane

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

201-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Newborn screening for hemoglobinopathies in Colorado. The first 10 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Bacteremia in sickle hemoglobinopathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Infection Caused by Streptococcus pneumoniae in Children with Sickle Cell Disease: Epidemiology, Immunologic Mechanisms, Prophylaxis, and Vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Immediate hypersensitivity reactions to beta-lactam antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Clinical presentation of homozygous sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Bacteremia in children with sickle hemoglobin C disease and sickle beta(+)-thalassemia: is prophylactic penicillin necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Neonatal screening for sickle cell disease: a cost-effectiveness analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Markov models in medical decision making: a practical guide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Cost-effectiveness of routine coronary angiography after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Cost-effectiveness of a coronary care unit versus an intermediate care unit for emergency department patients with chest pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Is universal neonatal hemoglobinopathy screening cost-effective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

A cost-effectiveness evaluation of newborn hemoglobinopathy screening from the perspective of state health care systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Five-hundred life-saving interventions and their cost-effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

Immediate hypersensitivity reactions to penicillin and related antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2800%2970102-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(00)70102-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10657826%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference